maxwell pardon

Mon, 04 May 2026 22:48:30 +0000

ISP-001 was developed using Immusofts proprietary platform ISP (Immune System Programming). To manufacture the cell product, Immusoft also uses technology related to the. Our approach, called Immune System Programming (ISP) entails collecting a type of the patients immune cells, called B cells. In response to immune stimulation, B cells can turn into biofactories. Immusoft acquired the system when it bought Discovery Genomics in 2016 for an undisclosed price, gaining a license to use Sleeping Beauty for MPS I plus options to license the... Safety and initial activity of autologous human B cells genetically engineered to express human iduronidase using the Sleeping Beauty transposon system. Results from a first-in-human...